Sorin Group S.p.A. Announces First North American Implant of the Freedom Solo Pericardial Aortic Valve

Sorin Group, (Reuters Code: SORN.MI) (MIL:SRN), a global medical device company and a leader in the treatment of cardiovascular diseases, today announced the first North American implant of the Freedom Solo™ aortic valve, performed at Hopital Laval, Division of Cardiac Surgery in Quebec City, Quebec, Canada.

MORE ON THIS TOPIC